CCNG2 and breast carcinoma: Metastatic breast cancer cells (MBC) could secrete and transport miR-1246 to mammary epithelial cells and nonmetastatic breast cancer cells to suppress the expression of cyclin-g2, thereby enhancing survival rates and mobility of breast cancer cells [6].